5 questions answered from cited research · Plain language
Multiple T cell subsets are involved in PBC, including CD4+ Th17/Treg imbalance, CD8+ T cells, Tfh, Tph, and unconventional T cells like γδ T, MAIT, and iNKT cells.
Read the full answer →Yes, seladelpar improves liver function in primary biliary cholangitis by reducing alkaline phosphatase (ALP) and bilirubin levels, especially in patients with compensated cirrhosis.
Read the full answer →Yes, PPAR agonists (bezafibrate, elafibranor, seladelpar) significantly reduce itching in primary biliary cholangitis, especially in those with moderate-to-severe symptoms.
Read the full answer →About one-third, or 33%, of patients with primary biliary cholangitis experience pruritus, which is the second most common symptom after fatigue.
Read the full answer →Severe fatigue affects about 20-23% of patients with primary biliary cholangitis, based on systematic reviews and large cohort studies.
Read the full answer →